Oxybutynin hydrochloride

CAS No. 1508-65-2

Oxybutynin hydrochloride( MJ4309-1 )

Catalog No. M12107 CAS No. 1508-65-2

Oxybutynin is also a possible treatment of hyperhidrosis (hyper-active sweating) .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 32 In Stock
100MG 43 In Stock
500MG 87 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Oxybutynin hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Oxybutynin is also a possible treatment of hyperhidrosis (hyper-active sweating) .
  • Description
    Oxybutynin is also a possible treatment of hyperhidrosis (hyper-active sweating) .(In Vitro):Oxybutynin chloride (0.1, 0.3, 1, 3, 10, 30, 100 μM; 200 ms) inhibits vascular Kv channels in a concentration-dependent manner independent of anticholinergic effect in coronary arterial smooth muscle cells. (In Vivo):Oxybutynin chloride (27.2 mg/kg; p.o.; single) exhibits significant binding of mouse brain muscarinic receptors that about a 2-fold increase in Kd values for specific [3H]N-methylscopolamine binding 0.5 and 2 h later.
  • In Vitro
    Oxybutynin chloride (0.1, 0.3, 1, 3, 10, 30, 100 μM; 200 ms) inhibits vascular Kv channels in a concentration-dependent manner independent of anticholinergic effect in coronary arterial smooth muscle cells. Cell Viability Assay Cell Line:Coronary arterial smooth muscle cells (from Male New Zealand White rabbits)Concentration:10 μM Incubation Time:200 ms Result:Rapidly inhibited the Kv current within 2 min and reduced the Kv current by 44% at +60 Mv.Inhibited the Kv current by changing the gating properties of Kv channels.Cell Viability Assay Cell Line: Coronary arterial smooth muscle cells (from male New Zealand White rabbits)Concentration:0.1, 0.3, 1, 3, 10, 30, 100 μM Incubation Time:200 ms Result:Reduced the Kv current amplitude in a concentration-dependent manner, with an IC50 value of 11.51 μM.
  • In Vivo
    Oxybutynin chloride (27.2 mg/kg; p.o.; single) exhibits significant binding of mouse brain muscarinic receptors that about a 2-fold increase in Kd values for specific [3H]N-methylscopolamine binding 0.5 and 2 h later. Animal Model:Male ddY strain mice (9 to 13-week-old).Dosage:27.2 mg/kg (76.1 μmol/kg) Administration:Oral administration; single.Result:Significant increased Kd values for specific [3H]NMS binding in mouse bladder with values of 54.7% and 40.6% when at 0.5 and 2 hours, respectively. Significant increased Kd values for specific [3H]NMS binding in mouse cerebral cortex with values of 120% and 71.2% when at 0.5 and 2 hours, respectively.
  • Synonyms
    MJ4309-1
  • Pathway
    Endocrinology/Hormones
  • Target
    AChR
  • Recptor
    mAChR
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    1508-65-2
  • Formula Weight
    393.96
  • Molecular Formula
    C22H32ClNO3
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 79 mg/mL (200.53 mM); Water: 4 mg/mL (10.15 mM); DMSO: 79 mg/mL (200.53 mM)
  • SMILES
    O=C(OCC#CCN(CC)CC)C(O)(C1CCCCC1)C2=CC=CC=C2.[H]Cl
  • Chemical Name
    4-Diethylaminobut-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylethanoate Hydrochloride

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ito Y, et al. Eur J Pharmacol. 2009 Aug 1;615(1-3):201-6.
molnova catalog
related products
  • Primidone

    Primidone is an anticonvulsant of the pyrimidinedione class.

  • AVex-73

    AVex-73 is a muscarinic M1 agonist potentially for the treatment of Alzheimer's disease.

  • Thymidine

    Thymidine overload due to Thymidine phosphorylase deficiency, and mitochondrial toxicity caused by antiviral Thymidine analogues.